Komipharm International Co., Ltd. (KOSDAQ: 041960)

Market Cap	277.11B
Revenue (ttm)	54.53B
Net Income (ttm)	11.34B
Shares Out	69.28M
EPS (ttm)	164.14
PE Ratio	24.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,413
Open	3,980.00
Previous Close	4,020.00
Day's Range	3,970.00 - 4,020.00
52-Week Range	3,610.00 - 5,640.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About Komipharm International

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. The company manufactures veterinary drugs in injectable, powder, oral solution, topical solution, disinfectant, and other forms. It is also developing anticancer drugs and cancer pain-relieving agents for human health and life. In addition, the company also engages in clinical pathological experiment, test, and analysis activities. The company was formerly known as Korea Microbiological...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1972
• Employees: 158
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041960

Financial Performance

In 2023, Komipharm International's revenue was 42.65 billion, an increase of 7.15% compared to the previous year's 39.80 billion. Losses were -3.98 billion, -38.91% less than in 2022.